Patent EP0010205A1 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0010205A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

5-Substituted 1-(2'-deoxy-2'-substituted-beta-D-arabinofuranosyl) pyrimidine nucleosides and pharmaceutical compositions containing them

Assignee: Memorial Sloan Kettering Cancer Center
•
Filing: 1979-09-27
•
Granted: —
•
Expires: 1999-09-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1. Pyrimidine nucleosides exhibiting anti-viral and anti-tumor effects have the formula wherein A is OR', SR', NR 3 R 4 or NHacyl wherein R' and R' are the same or different and are hydrogen, lower alkyl of 1 to 7 carbon atoms, aralkyl, or aryl; NHacyl is alkanoyl or aroyl amide; B is oxygen or sulfur; X is halogen, alkylsulfonyl or arylsulfonyl; Y is halogen, amino, monoalkyl- or monoaralkylamino, dialkylamino, aminomethyl, hydroxymethyl, lower alkyl, aryl, aralkyl, vinyl and substituted vinyl or ethynyl and substituted ethynyl; Z is methyne or nitrogen; R 1 and R 2 are the same or different and are hydrogen acyl or aroyl.

Inventors

  • 👤 Carlos Lopez
  • 👤 Kyoichi A. Watanabe
  • 👤 Uri Reichman
  • 👤 Jack J. Fox

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-09 03:03
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06; A; A61; A61P; A61P31/00; A61P31/04; A61P31/12; A61P35/00; C07H19/12

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 108 words
Pyrimidine nucleosides having the formula wherein A is O R 3 , S R 3 , NR 3 R 4 or NHacyl wherein R 3 and R 4 are the same or different and are hydrogen, lower alkyl of 1 to 7 carbon atoms, aralkyl, or aryl; NHacyl is alkanoyl or aroyl amide; B is oxygen or sulfur; X is halogen, alkylsulfonyl or arylsulfonyl; Y is halogen, amino, monoalkyl- or monoaralkylamino, dialkylamino, aminomethyl, hydroxymethyl, lower alkyl, aryl, aralkyl, vinyl and substituted vinyl or ethynyl and substituted ethynyl; Z is methyne or nitrogen; R 1 and R 2 are the same or different and are hydrogen acyl or aroyl.
Claim 2
Dependent Claim 108 words
Pyrimidine nucleosides having the formula wherein A is O R 3 , S R 3 , NR 3 R 4 or NHacyl wherein R 3 and R 4 are the same or different and are hydrogen, lower alkyl of 1 to 7 carbon atoms, aralkyl, or aryl; NHacyl is alkanoyl or aroyl amide; B is oxygen or sulfur; X is halogen, alkylsulfonyl or arylsulfonyl; Y is halogen, amino, monoalkyl- or monoaralkylamino, dialkylamino, aminomethyl, hydroxymethyl, lower alkyl, aryl, aralkyl, vinyl and substituted vinyl or ethynyl and substituted ethynyl; Z is methyne or nitrogen; R 1 and R 2 are the same or different and are hydrogen acyl or aroyl.
Claim 3
Dependent Claim 39 words
Nucleosides of Cl 1 selected from the group of 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-chlorocytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-bromocytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodocytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)- 5-methylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-I 5-ethylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-benzylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-vinylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethynylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-aminocytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-benzylaminocytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-aminomethylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-hydroxymethylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methyl-6-azacytosine, 1-(3,5-di-0-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl) 5-fluorocytosine, 1-(3,5-di-0-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl) 5-chlorocytosine, 1-(3,5-di-0-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-bromocytosine, 1-(3,5-di-0-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine, 1-(3,5-di-0-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-methylcytosine, 1-(3,5-di-0-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-methyl-6-azacytosine, 1-(3,5-di-0-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-fluorocytosine, 1-(3,5-di-0-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-chlorocytosine, 1-(3,5-di-0-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-bromocytosine. 1-(3,5-di-0-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine, 1-(3,5-di-0-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-methylcytosine, 1-(3,5-di-0-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-methyl-6-azacytosine.
Claim 4
Dependent Claim 39 words
Nucleosides of Cl 1 selected from the group of 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-chlorocytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-bromocytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodocytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)- 5-methylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-I 5-ethylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-benzylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-vinylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethynylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-aminocytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-benzylaminocytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-aminomethylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-hydroxymethylcytosine, 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methyl-6-azacytosine, 1-(3,5-di-0-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl) 5-fluorocytosine, 1-(3,5-di-0-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl) 5-chlorocytosine, 1-(3,5-di-0-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-bromocytosine, 1-(3,5-di-0-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine, 1-(3,5-di-0-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-methylcytosine, 1-(3,5-di-0-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-methyl-6-azacytosine, 1-(3,5-di-0-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-fluorocytosine, 1-(3,5-di-0-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-chlorocytosine, 1-(3,5-di-0-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-bromocytosine. 1-(3,5-di-0-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine, 1-(3,5-di-0-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-methylcytosine, 1-(3,5-di-0-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-methyl-6-azacytosine.
Claim 5
Dependent Claim 26 words
Nucleosides of Cl 1 selected from the group of 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-B-B-arabinofuranosyl)-5-fluorouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-chlorouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-bromouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-6-azathymine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-fluorouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-chlorouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-bromouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deaxy-β-D-arabinofuranosyl)-5-iodouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-thymine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-6-azathymine, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-fluorouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-chlorouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-bromouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-iodouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-thymine, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-6-azathymine.
Claim 6
Dependent Claim 26 words
Nucleosides of Cl 1 selected from the group of 1-(3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-B-B-arabinofuranosyl)-5-fluorouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-chlorouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-bromouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodouracil, 1-(3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-6-azathymine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-fluorouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-chlorouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-bromouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deaxy-β-D-arabinofuranosyl)-5-iodouracil, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-thymine, 1-(3,5-di-O-acetyl-2-chloro-2-deoxy-β-D-arabinofuranosyl)-6-azathymine, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-fluorouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-chlorouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-bromouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-iodouracil, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-thymine, 1-(3,5-di-O-acetyl-2-bromo-2-deoxy-β-D-arabinofuranosyl)-6-azathymine.
Claim 7
Dependent Claim 16 words
Nucleosides of Cl 1 selected from the group of 1-(2-deoxy-2-fluoro-S-D-drabinofuranosyl)-5-bromocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-chlorocytosine, ; 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-fluorocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodocytosine and 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methylcytosine.
Claim 8
Dependent Claim 16 words
Nucleosides of Cl 1 selected from the group of 1-(2-deoxy-2-fluoro-S-D-drabinofuranosyl)-5-bromocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-chlorocytosine, ; 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-fluorocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodocytosine and 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methylcytosine.
Claim 9
Dependent Claim 45 words
Nucleosides of Cl 1 selected from the group of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-benzylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-S-vinylcytosine, 1-(2-deoxy-2-fluoro-S-D-arabinofuranosyl)-5-ethynylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-aminocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-benzylaminocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-aminomethylcytosine, 1-(2-deoxy-2-fluoro-S-D-arabinofuranosyl)-5-hydroxymethylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methyl-6-azacytosine, 1-(2-chloro-2-deohy-β-D-arabinofuranosyl)-5-fluorocytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-chlorocytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-bromocytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arab inofuranosyl)-5-iodocytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-methylcytosine hydrochloride 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-methyl-6-azacytosine hydrochloride, 1-(2-bromo-2-debxy-β-D-arabinofuranosyl)-5-fluorocytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-chlorocytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-bromocytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-S-iodocytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-methylcytosine hydrochloride, and 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-methyl-6-azacytosine hydrochloride.
Claim 10
Dependent Claim 45 words
Nucleosides of Cl 1 selected from the group of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-benzylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-S-vinylcytosine, 1-(2-deoxy-2-fluoro-S-D-arabinofuranosyl)-5-ethynylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-aminocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-benzylaminocytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-aminomethylcytosine, 1-(2-deoxy-2-fluoro-S-D-arabinofuranosyl)-5-hydroxymethylcytosine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methyl-6-azacytosine, 1-(2-chloro-2-deohy-β-D-arabinofuranosyl)-5-fluorocytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-chlorocytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-bromocytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arab inofuranosyl)-5-iodocytosine hydrochloride, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-methylcytosine hydrochloride 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-methyl-6-azacytosine hydrochloride, 1-(2-bromo-2-debxy-β-D-arabinofuranosyl)-5-fluorocytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-chlorocytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-bromocytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-S-iodocytosine hydrochloride, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-methylcytosine hydrochloride, and 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-methyl-6-azacytosine hydrochloride.
Claim 11
Dependent Claim 15 words
Nucleosides of claim 1 selected from the group of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)thymine, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-fluorouracil, 1-(2-deoxy-2-fluoro-B-D-arabinofuranosyl)-5-chlorouracil, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-bromouracil and 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodouracil.
Claim 12
Dependent Claim 23 words
Nucleosides of claim 1 selected from the group of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-6-azathymine, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-fluorouracil, 1-(2-chloro-2-deoxy-B-D-arabinofuranosyl)-5-chlorouracil, 1-(2-chlaro-2-deoxy-β-D-arabinofuranosyl)-5-bromouracil, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-5-iodouracil, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)thymine, 1-(2-chloro-2-deoxy-β-D-arabinofuranosyl)-6-azathymine, 1-(2-bromo-2-deoxy-S-D-arabinofuranosyl)-5-fluorouracil, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-chlorouracil, 1-(2-bromo-2-deoxy-β-D-arabin6furanosyl)-5-bromouracil, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)-5-iodouracil, 1-(2-bromo-2-deoxy-β-D-arabinofuranosyl)thymine and 1-(2-bromo-2-deoxy-R-D-arabinofuranosyl)-6-azathymine.
Claim 13
Dependent Claim 31 words
Pharmaceutical composition comprising an effective amount of a nucleoside of the formula defined in claim 1 or of a pharmaceutically acceptable acid addition salt thereof together with a pharmaceutically acceptable carrier.
Claim 14
Dependent Claim 37 words
Method of producing an anti-viral effect in a warm-blooded animal which comprises administering to said anima an effective amount of a nucleoside of the formula defined in claim 1 or a pharmaceutically acceptable acid addition salt thereof.
Claim 15
Dependent Claim 37 words
lo. Method of producing anti-tumor effect in a warm-blooded animal which comprises administering to said animal an effective amount of a nucleoside of the formula defined in claim 1 or a pharmaceutically acceptable acid addition salt thereof.

References Cited (Backward Citations)

US3282921A Cited
US3870700A Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag